Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v2-FR
Language French French
Date Updated 2019-12-11 2019-11-06
Drug Identification Number 02479974 02479974
Brand name MYCOPHENOLATE MOFETIL FOR INJECTION USP MYCOPHENOLATE MOFETIL FOR INJECTION USP
Common or Proper name MYCOPHENOLATE MOFETIL FOR INJECTION USP MYCOPHENOLATE MOFETIL FOR INJECTION USP
Company Name STERIMAX INC STERIMAX INC
Ingredients MYCOPHENOLATE MOFETIL MYCOPHENOLATE MOFETIL
Strength(s) 500MG 500MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 4 VIALS 4 VIALS
ATC code L04AA L04AA
ATC description IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-11-06 2019-11-06
Actual start date
Estimated end date 2019-12-02 2019-12-02
Actual end date 2019-12-03
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments 100% Monthly allocation at McKesson based on historical demand.
Health Canada comments